Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
ORTHOPAEDICS	O
Allergies:	O
Sulfa	O
(Sulfonamide	O
Antibiotics)	O
/	O
niacin	O
Attending:	O
___	O
Chief	O
Complaint:	O
Right	O
leg	O
pain	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
___	O
Right	O
femoral	O
shaft	O
IMN	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
a	O
___	O
y/o	O
female	O
who	O
presents	O
s/p	O
fall/guided	B-Falls
landing	O
during	O
transfer	O
from	O
bed	O
to	O
wheelchair.	B-Mobile_with_aid
Pt	O
denies	O
head	O
trauma	O
or	O
LOC.	O
Right	O
knee	O
buckled	O
and	O
now	O
c/o	O
pain	O
and	O
swelling	O
to	O
that	O
knee.	O
She	O
has	O
a	O
history	O
of	O
right	O
knee	O
instability	O
and	O
recent	O
admission	O
for	O
humeral	B-Proximal_humeral_fracture
fx	B-Proximal_humeral_fracture
on	O
___	O
currently	O
being	O
treated	O
non-operatively	O
in	O
a	O
splint.	O
Past	O
Medical	O
History:	O
Ulcerative	O
colitis:	O
s/p	O
protocolectomy	O
and	O
end	O
ileostomy	O
(___)	O
B12	O
replacement	O
HTN	O
HLD	O
Hypothyroidism	O
Depression	O
Anxiety	O
GERD	O
Spinal	O
stenosis	O
Restless	O
leg	O
syndrome	O
Urinary	O
frequency	O
Social	O
History:	O
___	O
Family	O
History:	O
Non	O
contributory	O
Physical	O
Exam:	O
Vital	O
Signs:	O
97.4	O
84	O
141/73	O
16	O
93%	O
ra	O
Gen:	O
NAD,	O
Calm	O
and	O
comfortable	O
Upper	O
Extremities:	O
LUE	O
in	O
sling	O
Skin	O
clean	O
and	O
intact	O
Arms	O
and	O
forearm	O
compartments	O
soft	O
No	O
pain	O
with	O
passive	O
motion	O
SILT	O
in	O
the	O
Axillary,	O
Radial,	O
Median,	O
Ulnar	O
nerve	O
distributions	O
motor	O
intact	O
for	O
EPL	O
FPL	O
EIP	O
EDC	O
FDP	O
FDI	O
2+	O
radial	O
pulses	O
Lower	O
Extremities:	O
BLE	O
skin	O
clean	O
and	O
intact	O
Gross	O
deformity,	O
shortening,	O
external	O
rotation	O
of	O
right	O
thigh	O
No	O
other	O
tenderness,	O
deformity,	O
erythema,	O
edema,	O
induration	O
or	O
ecchymosis	O
Thighs	O
and	O
leg	O
compartments	O
soft	O
No	O
pain	O
with	O
passive	O
motion	O
Saphenous,	O
Sural,	O
Deep	O
peroneal,	O
Superficial	O
peroneal	O
SILT	O
___	O
FHS	O
___	O
TA	O
Peroneals	O
Fire	O
1+	O
___	O
and	O
DP	O
pulses	O
Pertinent	O
Results:	O
___	O
10:41AM	O
GLUCOSE-142*	O
UREA	O
N-17	O
CREAT-1.2*	O
SODIUM-138	O
POTASSIUM-4.8	O
CHLORIDE-105	O
TOTAL	O
CO2-24	O
ANION	O
GAP-14	O
___	O
10:41AM	O
CALCIUM-8.2*	O
PHOSPHATE-3.6	O
MAGNESIUM-2.0	O
___	O
10:40AM	O
WBC-16.7*#	O
RBC-3.77*	O
HGB-10.0*	O
HCT-33.7*	O
MCV-90	O
MCH-26.6*	O
MCHC-29.7*	O
RDW-15.8*	O
___	O
10:40AM	O
PLT	O
COUNT-310	O
___	O
11:20PM	O
GLUCOSE-115*	O
UREA	O
N-19	O
CREAT-1.0	O
SODIUM-137	O
POTASSIUM-5.8*	O
CHLORIDE-106	O
TOTAL	O
CO2-22	O
ANION	O
GAP-15	O
___	O
11:20PM	O
estGFR-Using	O
this	O
___	O
11:20PM	O
COMMENTS-GREEN	O
TOP	O
___	O
11:20PM	O
K+-4.1	O
___	O
11:20PM	O
WBC-10.4	O
RBC-4.31	O
HGB-11.5*	O
HCT-38.2	O
MCV-89	O
MCH-26.6*	O
MCHC-30.0*	O
RDW-15.9*	O
___	O
11:20PM	O
NEUTS-76.5*	O
LYMPHS-16.5*	O
MONOS-5.8	O
EOS-0.9	O
BASOS-0.2	O
___	O
11:20PM	O
PLT	O
COUNT-328#	O
___	O
11:20PM	O
___	O
PTT-31.5	O
___	O
Brief	O
Hospital	O
Course:	O
The	O
patient	O
presented	O
to	O
the	O
emergency	O
department	O
and	O
was	O
evaluated	O
by	O
the	O
orthopedic	O
surgery	O
team.	O
The	O
patient	O
was	O
found	O
to	O
have	O
a	O
right	O
femoral	O
shaft	O
fracture	O
and	O
was	O
admitted	O
to	O
the	O
orthopedic	O
surgery	O
service.	O
The	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
on	O
___	O
for	O
R	O
femur	O
IMN,	O
which	O
the	O
patient	O
tolerated	O
well	O
(for	O
full	O
details	O
please	O
see	O
the	O
separately	O
dictated	O
operative	O
report).	O
The	O
patient	O
was	O
taken	O
from	O
the	O
OR	O
to	O
the	O
PACU	O
in	O
stable	O
condition	O
and	O
after	O
recovery	O
from	O
anesthesia	O
was	O
transferred	O
to	O
the	O
floor.	O
Musculoskeletal:	O
Prior	O
to	O
operation,	O
patient	O
was	O
NWB	O
RLE.	O
After	O
procedure,	O
patient's	O
weight-bearing	O
status	O
was	O
transitioned	O
to	O
WBAT	O
RLE.	O
Throughout	O
the	O
hospitalization,	O
patient	O
worked	O
with	O
physical	O
therapy	O
who	O
determined	O
that	O
discharge	O
to	O
a	O
rehab	O
facility	O
was	O
appropriate.	O
Neuro:	O
Post-operatively,	O
patient's	O
pain	O
was	O
controlled	O
by	O
IV	O
pain	O
medications	O
and	O
was	O
subsequently	O
transitioned	O
to	O
oxycodone	O
with	O
good	O
effect	O
and	O
adequate	O
pain	O
control.	O
CV:	O
The	O
patient	O
was	O
stable	O
from	O
a	O
cardiovascular	O
standpoint;	O
vital	O
signs	O
were	O
routinely	O
monitored.	O
Hematology:	O
The	O
patient	O
was	O
transfused	O
2	O
units	O
of	O
blood	O
for	O
acute	O
blood	O
loss	O
anemia.	O
Pulmonary:	O
The	O
patient	O
was	O
stable	O
from	O
a	O
pulmonary	O
standpoint;	O
vital	O
signs	O
were	O
routinely	O
monitored.	O
GI/GU:	O
A	O
po	O
diet	O
was	O
tolerated	O
well.	O
Patient	O
was	O
also	O
started	O
on	O
a	O
bowel	O
regimen	O
to	O
encourage	O
bowel	O
movement.	O
Intake	O
and	O
output	O
were	O
closely	O
monitored.	O
ID:	O
The	O
patient	O
received	O
perioperative	O
antibiotics.	O
The	O
patient's	O
temperature	O
was	O
closely	O
watched	O
for	O
signs	O
of	O
infection.	O
Prophylaxis:	O
The	O
patient	O
received	O
enoxaparin	O
during	O
this	O
stay,	O
and	O
was	O
encouraged	O
to	O
get	O
up	O
and	O
ambulate	O
as	O
early	O
as	O
possible.	O
At	O
the	O
time	O
of	O
discharge	O
on	O
___,	O
POD	O
#3,	O
the	O
patient	O
was	O
doing	O
well,	O
afebrile	O
with	O
stable	O
vital	O
signs,	O
tolerating	O
a	O
regular	O
diet,	O
ambulating,	O
voiding	O
without	O
assistance,	O
and	O
pain	O
was	O
well	O
controlled.	O
The	O
incision	O
was	O
clean,	O
dry,	O
and	O
intact	O
without	O
evidence	O
of	O
erythema	O
or	O
drainage;	O
the	O
extremity	O
was	O
NVI	O
distally	O
throughout.	O
The	O
patient	O
was	O
given	O
written	O
instructions	O
concerning	O
precautionary	O
instructions	O
and	O
the	O
appropriate	O
follow-up	O
care.	O
The	O
patient	O
will	O
be	O
continued	O
on	O
chemical	O
DVT	O
prophylaxis	O
for	O
2	O
weeks	O
post-operatively.	O
All	O
questions	O
were	O
answered	O
prior	O
to	O
discharge	O
and	O
the	O
patient	O
expressed	O
readiness	O
for	O
discharge.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q6H:PRN	O
fever	O
or	O
pain	O
2.	O
Alendronate	O
Sodium	O
70	O
mg	O
PO	O
QWED	O
3.	O
Aluminum-Magnesium	O
Hydrox.-Simethicone	O
15	O
mL	O
PO	O
QID:PRN	O
indigestion/dyspepsia	O
4.	O
Amlodipine	O
5	O
mg	O
PO	O
DAILY	O
5.	O
BuPROPion	O
(Sustained	O
Release)	O
100	O
mg	O
PO	O
QAM	O
6.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
EVERY	O
OTHER	O
DAY	O
7.	O
Levothyroxine	O
Sodium	O
112	O
mcg	O
PO	O
DAILY	O
8.	O
Lorazepam	O
0.5	O
mg	O
PO	O
HS	O
9.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
10.	O
OxycoDONE	O
(Immediate	O
Release)	O
5	O
mg	O
PO	O
Q6H:PRN	O
pain	O
11.	O
Pravastatin	O
80	O
mg	O
PO	O
DAILY	O
12.	O
Pregabalin	O
75	O
mg	O
PO	O
BID	O
13.	O
Ropinirole	O
0.5	O
mg	O
PO	O
QPM	O
14.	O
Sertraline	O
200	O
mg	O
PO	O
DAILY	O
15.	O
Cepastat	O
(Phenol)	O
Lozenge	O
1	O
LOZ	O
PO	O
Q2H:PRN	O
sore	O
throat	O
16.	O
Guaifenesin	O
___	O
mL	O
PO	O
Q6H:PRN	O
cough	O
17.	O
camphor-menthol	O
___	O
%	O
topical	O
BID	O
PRN	O
itching	O
18.	O
Cyanocobalamin	O
1000	O
mcg	O
IM/SC	O
Q	O
2	O
MONTHS	O
19.	O
LOPERamide	O
2	O
mg	O
PO	O
Q4H:PRN	O
diarrhea	O
20.	O
Lorazepam	O
0.5	O
mg	O
PO	O
Q6H:PRN	O
anxiety,	O
agitation	B-Delirium
21.	O
MetFORMIN	O
(Glucophage)	O
500	O
mg	O
PO	O
DAILY	O
22.	O
Miconazole	O
Powder	O
2%	O
1	O
Appl	O
TP	O
BID:PRN	O
yeast	O
23.	O
Vagifem	O
(estradiol)	O
10	O
mcg	O
vaginal	O
2x/week	O
24.	O
Vitamin	O
D	O
50,000	O
UNIT	O
PO	O
Q	O
3	O
WEEKS	O
Discharge	O
Medications:	O
1.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q6H:PRN	O
fever	O
or	O
pain	O
2.	O
Amlodipine	O
5	O
mg	O
PO	O
DAILY	O
3.	O
BuPROPion	O
(Sustained	O
Release)	O
100	O
mg	O
PO	O
QAM	O
4.	O
Cepastat	O
(Phenol)	O
Lozenge	O
1	O
LOZ	O
PO	O
Q2H:PRN	O
sore	O
throat	O
5.	O
Ferrous	O
Sulfate	O
325	O
mg	O
PO	O
EVERY	O
OTHER	O
DAY	O
6.	O
Guaifenesin	O
___	O
mL	O
PO	O
Q6H:PRN	O
cough	O
7.	O
Levothyroxine	O
Sodium	O
112	O
mcg	O
PO	O
DAILY	O
8.	O
LOPERamide	O
2	O
mg	O
PO	O
Q4H:PRN	O
diarrhea	O
9.	O
Lorazepam	O
0.5	O
mg	O
PO	O
HS	O
10.	O
Lorazepam	O
0.5	O
mg	O
PO	O
Q6H:PRN	O
anxiety,	O
agitation	B-Delirium
11.	O
Miconazole	O
Powder	O
2%	O
1	O
Appl	O
TP	O
BID:PRN	O
yeast	O
12.	O
Omeprazole	O
20	O
mg	O
PO	O
DAILY	O
13.	O
Pravastatin	O
80	O
mg	O
PO	O
DAILY	O
14.	O
Pregabalin	O
75	O
mg	O
PO	O
BID	O
15.	O
Ropinirole	O
0.5	O
mg	O
PO	O
QPM	O
16.	O
Sertraline	O
200	O
mg	O
PO	O
DAILY	O
17.	O
OxycoDONE	O
(Immediate	O
Release)	O
2.5-5	O
mg	O
PO	O
Q4H:PRN	O
pain	O
RX	O
*oxycodone	O
5	O
mg	O
___	O
tablet(s)	O
by	O
mouth	O
every	O
four	O
(4)	O
hours	O
Disp	O
#*50	O
Tablet	O
Refills:*0	O
18.	O
Aluminum-Magnesium	O
Hydrox.-Simethicone	O
15	O
mL	O
PO	O
QID:PRN	O
indigestion/dyspepsia	O
19.	O
Vitamin	O
D	O
50,000	O
UNIT	O
PO	O
Q	O
3	O
WEEKS	O
20.	O
Vagifem	O
(estradiol)	O
10	O
mcg	O
vaginal	O
2x/week	O
21.	O
MetFORMIN	O
(Glucophage)	O
500	O
mg	O
PO	O
DAILY	O
22.	O
Cyanocobalamin	O
1000	O
mcg	O
IM/SC	O
Q	O
2	O
MONTHS	O
23.	O
camphor-menthol	O
___	O
%	O
topical	O
BID	O
PRN	O
itching	O
24.	O
Senna	O
17.2	O
mg	O
PO	O
HS	O
25.	O
Enoxaparin	O
Sodium	O
40	O
mg	O
SC	O
QPM	O
Duration:	O
14	O
Days	O
Start:	O
Today	O
-	O
___,	O
First	O
Dose:	O
Next	O
Routine	O
Administration	O
Time	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Right	O
femoral	O
shaft	O
fracture	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
MEDICATIONS:	O
-	O
Please	O
take	O
all	O
medications	O
as	O
prescribed	O
by	O
your	O
physicians	O
at	O
discharge.	O
-	O
Continue	O
all	O
home	O
medications	O
unless	O
specifically	O
instructed	O
to	O
stop	O
by	O
your	O
surgeon.	O
-	O
Do	O
not	O
drink	O
alcohol,	O
drive	O
a	O
motor	O
vehicle,	O
or	O
operate	O
machinery	O
while	O
taking	O
narcotic	O
pain	O
relievers.	O
-	O
Narcotic	O
pain	O
relievers	O
can	O
cause	O
constipation,	B-Constipation
so	O
you	O
should	O
drink	O
eight	O
8oz	O
glasses	O
of	O
water	O
daily	O
and	O
take	O
a	O
stool	O
softener	O
(colace)	O
to	O
prevent	O
this	O
side	O
effect.	O
ANTICOAGULATION:	O
-	O
Please	O
take	O
lovenox	O
40mg	O
daily	O
for	O
2	O
weeks	O
WOUND	O
CARE:	O
-	O
No	O
baths	O
or	O
swimming	O
for	O
at	O
least	O
4	O
weeks.	O
-	O
Any	O
stitches	O
or	O
staples	O
that	O
need	O
to	O
be	O
removed	O
will	O
be	O
taken	O
out	O
at	O
your	O
2-week	O
follow	O
up	O
appointment.	O
-	O
No	O
dressing	O
is	O
needed	O
if	O
wound	O
continues	O
to	O
be	O
non-draining.	O
ACTIVITY	O
AND	O
WEIGHT	O
BEARING:	O
-	O
WBAT	O
RLE,	O
range	O
of	O
motion	O
as	O
tolerated	O
Physical	O
Therapy:	O
-	O
WBAT	O
RLE,	O
ROMAT	O
Treatments	O
Frequency:	O
-	O
No	O
baths	O
or	O
swimming	O
for	O
at	O
least	O
4	O
weeks.	O
-	O
Any	O
stitches	O
or	O
staples	O
that	O
need	O
to	O
be	O
removed	O
will	O
be	O
taken	O
out	O
at	O
your	O
2-week	O
follow	O
up	O
appointment.	O
-	O
No	O
dressing	O
is	O
needed	O
if	O
wound	O
continues	O
to	O
be	O
non-draining.	O
Followup	O
Instructions:	O
___	O

